Estabrook Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.32M | Sell |
84,459
-4,245
| -5% | -$407K | 1.07% | 30 |
|
|
2025
Q4 | $8.52M | Sell |
88,704
-1,741
| -2% | -$169K | 1.25% | 23 |
|
|
2025
Q3 | $8.61M | Sell |
90,445
-1,273
| -1% | -$117K | 1.26% | 22 |
|
|
2025
Q2 | $8M | Sell |
91,718
-2,296
| -2% | -$195K | 1.23% | 22 |
|
|
2025
Q1 | $8.45M | Sell |
94,014
-3,894
| -4% | -$348K | 1.36% | 21 |
|
|
2024
Q4 | $7.82M | Sell |
97,908
-1,932
| -2% | -$167K | 1.21% | 23 |
|
|
2024
Q3 | $8.99M | Sell |
99,840
-741
| -0.7% | -$62.3K | 1.34% | 21 |
|
|
2024
Q2 | $7.92M | Sell |
100,581
-3,124
| -3% | -$256K | 1.22% | 23 |
|
|
2024
Q1 | $9.04M | Sell |
103,705
-365
| -0.4% | -$31.1K | 1.4% | 20 |
|
|
2023
Q4 | $8.57M | Sell |
104,070
-1,132
| -1% | -$86.3K | 1.4% | 20 |
|
|
2023
Q3 | $8.24M | Sell |
105,202
-5,213
| -5% | -$436K | 1.45% | 20 |
|
|
2023
Q2 | $9.73M | Sell |
110,415
-1,902
| -2% | -$164K | 1.62% | 17 |
|
|
2023
Q1 | $9.05M | Sell |
112,317
-470
| -0.4% | -$38.3K | 1.57% | 18 |
|
|
2022
Q4 | $8.77M | Sell |
112,787
-3,703
| -3% | -$300K | 1.51% | 20 |
|
|
2022
Q3 | $9.41M | Sell |
116,490
-671
| -0.6% | -$60.3K | 1.75% | 16 |
|
|
2022
Q2 | $10.5M | Sell |
117,161
-3,783
| -3% | -$383K | 1.8% | 17 |
|
|
2022
Q1 | $13.4M | Buy |
120,944
+3,396
| +3% | +$359K | 1.97% | 15 |
|
|
2021
Q4 | $12.2M | Sell |
117,548
-772
| -0.7% | -$89.4K | 1.72% | 14 |
|
|
2021
Q3 | $14.8M | Sell |
118,320
-5,604
| -5% | -$725K | 2.34% | 11 |
|
|
2021
Q2 | $15.4M | Sell |
123,924
-4,225
| -3% | -$530K | 2.34% | 10 |
|
|
2021
Q1 | $15.1M | Sell |
128,149
-1,290
| -1% | -$151K | 2.33% | 11 |
|
|
2020
Q4 | $15.2M | Sell |
129,439
-1,827
| -1% | -$201K | 2.51% | 9 |
|
|
2020
Q3 | $13.6M | Sell |
131,266
-3,053
| -2% | -$307K | 2.5% | 10 |
|
|
2020
Q2 | $12.3M | Sell |
134,319
-1,713
| -1% | -$164K | 2.34% | 11 |
|
|
2020
Q1 | $12.3M | Sell |
136,032
-5,454
| -4% | -$580K | 2.58% | 10 |
|
|
2019
Q4 | $16.1M | Sell |
141,486
-1,552
| -1% | -$170K | 2.41% | 12 |
|
|
2019
Q3 | $15.5M | Sell |
143,038
-2,684
| -2% | -$280K | 2.59% | 11 |
|
|
2019
Q2 | $14.2M | Sell |
145,722
-1,993
| -1% | -$182K | 2.32% | 14 |
|
|
2019
Q1 | $13.5M | Sell |
147,715
-935
| -0.6% | -$83.7K | 2.23% | 15 |
|
|
2018
Q4 | $13.5M | Sell |
148,650
-4,621
| -3% | -$432K | 2.51% | 13 |
|
|
2018
Q3 | $15.1M | Sell |
153,271
-6,789
| -4% | -$628K | 2.28% | 15 |
|
|
2018
Q2 | $13.7M | Sell |
160,060
-4,416
| -3% | -$369K | 2.16% | 18 |
|
|
2018
Q1 | $13.2M | Sell |
164,476
-2,808
| -2% | -$232K | 2.07% | 18 |
|
|
2017
Q4 | $13.5M | Sell |
167,284
-6,624
| -4% | -$531K | 2.04% | 15 |
|
|
2017
Q3 | $13.5M | Buy |
173,908
+8,984
| +5% | +$746K | 2.1% | 16 |
|
|
2017
Q2 | $14.6M | Sell |
164,924
-2,065
| -1% | -$174K | 2.33% | 12 |
|
|
2017
Q1 | $13.5M | Sell |
166,989
-307
| -0.2% | -$24K | 2.1% | 17 |
|
|
2016
Q4 | $11.9M | Sell |
167,296
-54,076
| -24% | -$4.25M | 1.87% | 20 |
|
|
2016
Q3 | $19.1M | Sell |
221,372
-2,842
| -1% | -$248K | 2.81% | 6 |
|
|
2016
Q2 | $19.5M | Sell |
224,214
-15,089
| -6% | -$1.22M | 2.91% | 6 |
|
|
2016
Q1 | $17.9M | Sell |
239,303
-9,613
| -4% | -$724K | 2.66% | 8 |
|
|
2015
Q4 | $19.1M | Sell |
248,916
-14,708
| -6% | -$1.11M | 2.77% | 7 |
|
|
2015
Q3 | $17.6M | Sell |
263,624
-10,224
| -4% | -$753K | 2.55% | 10 |
|
|
2015
Q2 | $20.3M | Sell |
273,848
-2,716
| -1% | -$208K | 2.51% | 11 |
|
|
2015
Q1 | $21.6M | Buy |
+276,564
| New | +$21M | 2.52% | 10 |
|
Other funds holding MDT
VCM
VPM
Estabrook Capital Management's MDT Position: Q1 2026 in Review
Estabrook Capital Management reduced its Medtronic (MDT) stake by 4.8% in Q1 2026, selling an estimated $407K and leaving 84,459 shares worth $7.32M. The position accounts for 1.07% of the portfolio, ranked #30.
Estabrook Capital Management first reported a position in MDT in Q1 2015 and has held it in 45 quarters since. The position peaked at $21.6M in Q1 2015. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Estabrook Capital Management held 84,459 shares of Medtronic worth $7.32M as of Q1 2026.
- Estabrook Capital Management sold 4,245 Medtronic shares in Q1 2026, an estimated $407K.
- Medtronic made up 1.07% of Estabrook Capital Management's portfolio in Q1 2026, its #30 holding.
- Estabrook Capital Management first reported a position in Medtronic in Q1 2015 and has held it in 45 quarters since.
- Estabrook Capital Management's Medtronic position peaked at $21.6M in Q1 2015.
- 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.